DEXTECH MEDICAL AB has a total of 25 patent applications. It decreased the IP activity by 83.0%. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), Canada and China. Its main competitors in its focus markets pharmaceuticals and macromolecular chemistry and polymers are SCPHARMACEUTICALS INC, HARVARD SCIENT CORP and CAVE HAROLD GORDON.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Canada | 3 | |
#3 | China | 3 | |
#4 | Israel | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Brazil | 2 | |
#7 | Finland | 2 | |
#8 | Mexico | 2 | |
#9 | United States | 2 | |
#10 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Holmberg Anders | 15 |
#2 | Nilsson Sten | 7 |
#3 | Holmberg Anders R | 7 |
#4 | Meurling Lennart | 7 |
#5 | Anders Holmberg | 2 |
#6 | Lennart Meurling | 1 |
Publication | Filing date | Title |
---|---|---|
FI20165515A | Modified dextran conjugates | |
CA2719295A1 | Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties | |
MX2009009533A | Modified hydroxypolymer conjugates with killing effect on tumor cells. |